Saturday, August 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Dividends

Matthews International Shares Face Dividend-Related Pressure

Dieter Jaworski by Dieter Jaworski
November 29, 2025
in Dividends
0
Matthews Stock
0
SHARES
48
VIEWS
Share on FacebookShare on Twitter

Investors in Matthews International Corporation witnessed notable share price weakness as the company approached its ex-dividend date. The equity declined 1.1% during Friday’s session, settling at $24.92 per share. Market observers attribute this downward movement to the impending dividend distribution.

Key Dividend Dates and Expected Impact

The machinery and equipment manufacturer will trade ex-dividend on December 1, 2025. This cutoff date means purchasers acquiring shares on or after this day will not receive the upcoming quarterly payment. The company has scheduled its dividend distribution for December 15, 2025.

Critical dividend details:
* Ex-dividend date: December 1, 2025
* Quarterly dividend per share: $0.255
* Payment date: December 15, 2025
* Expected share price adjustment: approximately 1.02%

Should investors sell immediately? Or is it worth buying Matthews?

The declared dividend represents exactly 1.02% of the current share value. Financial markets typically price this adjustment into equities on the ex-dividend date, suggesting Matthews International shares could open about 1.02% lower on December 1, assuming stable market conditions.

Market Position and Recent Performance

With a present market capitalization of $767.43 million, Matthews International maintains its standing within the small-cap segment. While the company has recorded a 2.96% gain year-to-date, recent dividend-related pressure and trading losses indicate the stock faces near-term headwinds.

Market participants now await December’s trading activity to determine whether the equity can rebound following the dividend-related adjustment. The company’s performance during this period will provide clearer signals about its short-term trajectory.

Ad

Matthews Stock: Buy or Sell?! New Matthews Analysis from August 7 delivers the answer:

The latest Matthews figures speak for themselves: Urgent action needed for Matthews investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 7.

Matthews: Buy or sell? Read more here...

Tags: Matthews
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF Stock
Dividends

Energy Deals, Bank Weightings and Car Warnings Keep VanEck Dividend ETF Near Record High

August 4, 2026
Aumann Stock
Dividends

Aumann’s Cash Hoard and Buyback Hangover Create a Pivotal Moment for Shareholders

July 23, 2026
Allianz Stock
Banking & Insurance

Allianz Hits Record High as AI-Led Restructuring Reshapes Workforce

July 11, 2026
Next Post
FTC Solar Stock

FTC Solar Shares: Sustainable Recovery or Temporary Rally?

Baozun Stock

Baozun's Profitability Challenge: A Tale of Two Business Segments

Akari Therapeutics Stock

Akari Therapeutics Faces Nasdaq Compliance Challenge Amid Volatile Trading

Recommended

Palantir Stock

Palantir Shares Face Valuation Pressures Despite Strong Earnings

9 months ago
BridgeBio Pharma Stock

BridgeBio Pharma Investors Await Critical Heart Drug Data

9 months ago
Ocugen Stock

Ocugen’s Fresh $130M Cushion Sets the Stage for a Data-Heavy July and a Pivotal Regulatory Filing

1 month ago
Airbnb Stock

Navigating Regulatory Headwinds and Innovation: Airbnb’s Strategic Crossroads

10 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor

French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee

MSCI World ETF: Index Provider Rewrites the Rulebook for Fast-Moving Stocks

Airbus’ Paradox: A Slightly Smaller Forecast That Nobody Seems to Mind

Almonty Industries Rebounds From Index-Driven Exit as Tungsten Calculus Shifts Westward

OHB’s Two-Faced Half-Year: Record Orders Mask a Profit Squeeze That Spooked the Market

Trending

Nel ASA Stock
Analysis

Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding

by Jackson Burston
August 7, 2026
0

The Norwegian electrolyser maker Nel ASA is living a split-screen reality. Its order intake just exploded by...

SANDISK Stock

SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market

August 7, 2026
Bitcoin Stock

Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins

August 7, 2026
Kioxia Stock

Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor

August 7, 2026
FALLBACK Stock

French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee

August 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding
  • SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market
  • Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com